|
18 February 2015 |
VEGAS LEX partner of 10th PharmBusiness Russia conferenceThe conference annually gathers the leading pharmaceutical market participants, including Russian and international pharmaceutical companies, drug manufacturers and pharmacy chains, as well as concerned government agencies and industry associations. The conference agenda will include the following sessions: § Main prospects for 2015 § Shaping a common pharmaceuticals market in the Eurasian Economic Union. Law and business: Regulatory initiatives review § A look into the future through macroeconomics and geopolitics. GM opinion on the pharmaceutical market trends and development strategies in 2015 § Market structure changes: What can a distributor offer Western producers? § Modern challenges for pharmaceutical company strategies § Legal aspects of the pharmaceutical market § Main trends in pharmaceutical production: which Russian companies lead the import-replacement drive Managing Partner Alexander Sitnikov will speak at the session on the shaping of a common pharmaceuticals market in the Eurasian Economic Union, law and business, and regulatory initiatives. He will talk about the most recent legislative changes and legal trends for 2015, which are bound to affect the industry. Other speakers at the conference will include Timofei Nizhegorodtsev, head of the public services and retail oversight at the Federal Anti-Monopoly Service; head of the State Duma Committee on Healthcare Sergei Kalashnikov; Yelena Maksimkina, director of the Department for Pharmacological Support and Regulation of the Circulation of Medical Supplies at the Ministry of Healthcare; Vladimir Shipkov, executive director of the Association of International Pharmaceutical Manufacturers; Director of the Institute for Health Economics Larisa Popovich; Vladislav Shestakov, Director of the State Institute for Medicines and Appropriate Practices; Yelena Gavrilova, head of the Chemistry, Biotechnology and Medicine Department at the Federal Institute of Industrial Property; Vladimir Semyonov, head of the Pharmaceuticals Department at the Federal Institute of Industrial Property; and Viktor Dmitriyev, general director of the Association of Russian Pharmaceutical Manufacturers. |
